Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

BACKGROUND: Arginine deiminase (ADI) is an enzyme that degrades arginine, an amino acid that is important for growth and development of normal and neoplastic cells. Melanoma cells are auxotrophic for arginine, because they lack argininosuccinatesynthetase (ASS), a key enzyme required for the synthes...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Ott, Patrick A., Carvajal, Richard D., Pandit-Taskar, Neeta, Jungbluth, Achim A., Hoffman, Eric W., Wu, Bor-Wen, Bomalaski, John S., Venhaus, Ralph, Pan, Linda, Old, Lloyd J., Pavlick, Anna C., Wolchok, Jedd D.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4169197/
https://ncbi.nlm.nih.gov/pubmed/22864522
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-012-9862-2
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items